Literature DB >> 11322370

The underlying diseases and follow-up in Taiwanese children screened by urinalysis.

C Y Lin1, C C Hsieh, W P Chen, L Y Yang, H H Wang.   

Abstract

To date, the underlying diseases and follow-up of Taiwanese children screened by urinalysis have not been reported. The grading of urine abnormalities varied from grade A (microscopic hematuria only), grade B (light proteinuria only), grade C (light proteinuria and microscopic hematuria) to grade D (heavy proteinuria). From January 1991 to August 1998, 630 students, aged 6-15 years and with positive urinary screening, were admitted to our hospital for further evaluation. Of these, 573 students had confirmed abnormal findings, 298 were boys, 275 were girls, and 294 students received a renal biopsy and have had regular follow-up visits. This study was designed to retrospectively elucidate: (1) the relationship between grading of urine abnormality and underlying disease; (2) the relationships among hypertension, grading of urine abnormality, and underlying disease; (3) the underlying disease of low serum C3 level; and (4) to determine whether urinary screening progressively decreased the number of students with end-stage renal disease (ESRD) annually. The results show that glomerular nephritis (GN) is still one of the major causes of urinary abnormalities. The most-important secondary GN was systemic lupus erythematosus (SLE) with lupus nephritis. One-quarter of the patients fulfilled at least four of the revised American Rheumatology Association (ARA) criteria for SLE at first administration, while the others who fulfilled only two to three of the revised ARA criteria had gradually developing signs and symptoms of SLE at follow-up. The percentage of SLE patients amongst anti-nuclear antibody (ANA) positive children was 72%. Membranoproliferative GN is very rare. The distribution of hypertension was 8.2% in grade A, 10.7% in grade B, 9.7% in grade C, and 28.9% in grade D urinary abnormality. There were statistical differences between grade D and either grade A or B or C (P<0.05). Lower serum C3 levels were found only in a minority of patients, including those with SLE. In this series, focal segmental glomerular sclerosis (FSGS) and active class IV lupus nephritis patients were found early enough to receive methylprednisolone pulse plus cyclosporine A therapy. To date there have been only 2 cases (5%) of FSGS with impaired renal function, and none of the lupus nephritis patients are in the predialysis stage. In conclusion, GN is still the major cause of urinary screening abnormality. ANA study is indicated in all Chinese students with abnormal urinary screening. The correlations between the severity of proteinuria and hypertension showed more-severe proteinuria in patients with nephritis as well as in those with hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11322370     DOI: 10.1007/s004670000529

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  11 in total

1.  Urinary Screening for Early Detection of Kidney Diseases.

Authors:  Kamlesh S Suthar; Aruna V Vanikar; Lovelesh A Nigam; Rashmi D Patel; Kamal V Kanodia; Umang G Thakkar; Paulin A Gandhi; Sheetal A Chandak; Amit V Prajapati; Minaxi H Patel
Journal:  Indian J Pediatr       Date:  2017-11-23       Impact factor: 1.967

2.  Benefit of urinalysis.

Authors:  Ahmad Shajari; Hamideh Shajari; Mohammad Hossein Fallah Zade; Karmella Kamali; Mohammad Rahim Kadivar; Forough Nourani
Journal:  Indian J Pediatr       Date:  2009-04-23       Impact factor: 1.967

3.  Efficacy of urine screening at school: experience in Shanghai, China.

Authors:  Yi-Hui Zhai; Hong Xu; Guang-Hua Zhu; Min-Jiang Wei; Bing-Chun Hua; Qian Shen; Jia Rao; Jie Ge
Journal:  Pediatr Nephrol       Date:  2007-10-18       Impact factor: 3.714

4.  Incidence and renal survival of ESRD in the young Taiwanese population.

Authors:  Tzu-Chun Tsai; Yu-Chun Chen; Chiao-Wei Lo; Wei-Shu Wang; Su-Shun Lo; Gau-Jun Tang; Peck-Foong Thien
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 8.237

5.  A nationwide study of mass urine screening tests on Korean school children and implications for chronic kidney disease management.

Authors:  Byoung-Soo Cho; Won-Ho Hahn; Hae Il Cheong; Inseok Lim; Cheol Woo Ko; Su-Young Kim; Dae-Yeol Lee; Tae-Sun Ha; Jin-Soon Suh
Journal:  Clin Exp Nephrol       Date:  2012-11-08       Impact factor: 2.801

6.  Epidemiological urinalysis of children from kindergartens of Can Gio, Ho Chi Minh City - Vietnam.

Authors:  Le Nhu Nguyet Dang; Thi Le Binh Doan; Ngoc Hue Doan; Thi Kim Hoa Pham; Françoise Smets; Mong Hiep Tran Thi; Françoise Janssen; Annie Robert
Journal:  BMC Pediatr       Date:  2013-11-11       Impact factor: 2.125

7.  Socio-Demographic Factors Affect the Prevalence of Hematuria and Proteinuria Among School Children in Hualien, Taiwan: A Longitudinal Localization-Based Cohort Study.

Authors:  Ming-Chun Chen; Jen-Hung Wang; Jui-Shia Chen; Yung-Chieh Chang; Rong-Hwa Jan; Shang-Hsien Yang; Shao-Yin Chu; Pei-Chun Lai; Chia-Hsiang Chu; Ching-Feng Cheng; Yu-Hsun Chang
Journal:  Front Pediatr       Date:  2020-12-10       Impact factor: 3.418

8.  Urinary screening for detection of renal abnormalities in asymptomatic school children.

Authors:  Prince Parakh; Nisha K Bhatta; Om P Mishra; Pramod Shrestha; Sunil Budhathoki; Shankar Majhi; Arvind Sinha; Kanchan Dhungel; Rahul Prabhakar; Niladri Haldhar
Journal:  Nephrourol Mon       Date:  2012-06-20

9.  Prevalence of hypertension, obesity, hematuria and proteinuria amongst healthy adolescents living in Western Saudi Arabia.

Authors:  Kholoud A Hothan; Bashaer A Alasmari; Omniya K Alkhelaiwi; Khalid M Althagafi; Abdulaziz A Alkhaldi; Ahmed K Alfityani; Muhannad M Aladawi; Sara N Sharief; Sherif El Desoky; Jameela A Kari
Journal:  Saudi Med J       Date:  2016-10       Impact factor: 1.484

10.  Urine analysis with dipstick test in asymptomatic 7-year-old children.

Authors:  Farahnaz Kamyab; Mahboobe Gholami; Fatemeh Shaghaghi; Mohammad Bidkhori; Zahra Kamali
Journal:  J Educ Health Promot       Date:  2020-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.